Foamy virus vectors: The usefulness of a perfect parasite

Gene Therapy

Volumn 15, Issue 19, 2008, Pages 1299-1301

  Vassilopoulos, G ^b   Rethwilm, A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; RETROVIRUS VECTOR; SPUMA VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIGEN EXPRESSION; ARTICLE; DOG; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENOME ANALYSIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHESION DEFICIENCY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SAFETY; TRANSCRIPTION INITIATION; VIRAL GENE THERAPY; VIRUS ISOLATION; VIRUS TRANSMISSION; ANIMAL; ANIMAL MODEL; GENE THERAPY; GENE VECTOR; GENETICS; METHODOLOGY; NOTE; SPUMA VIRUS;

HUMAN SPUMARETROVIRUS;

ANIMALS; DOGS; GENE THERAPY; GENETIC VECTORS; HUMANS; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; MODELS, ANIMAL; SPUMAVIRUS; TRANSDUCTION, GENETIC;

EID: 52049101127     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.129     Document Type: Article

References (43)

1. Bauer Jr TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM et al Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008; 14: 93-97.
2. Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006; 13: 1031-1049.
3. Malech HL, Hickstein DD. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: Chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol 2007; 14 29-36.
4. Roos D, Meischl C, de Boer M, Simsek S, Weening RS, Sanal O et al. Genetic analysis of patients with leukocyte adhesion deficiency: Genomic sequencing reveals otherwise undetectable mutations. Exp Hematol 2002; 30: 252-261.
5. Fischer A, Lisowska-Grospierre B, Anderson DC, Springer TA. Leukocyte adhesion deficiency: Molecular basis and functional consequences. Immunodefic Rev 1988; 1: 39-54.
6. Anderson DC, Schmalsteig FC, Finegold MJ, Hughes BJ, Rothlein R, Miller LJ et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: Their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152: 668-689.
7. Thomas C, Le Deist F, Cavazzana-Calvo M, Benkerrou M, Haddad E, Blanche S et al. Results of allogeneic bone marrow transplatitation in patients with leukocyte adhesion deficiency. Blood 1995; 86: 1629-1635.
8. Farinha NJ, Duval M, Wagner E, Champagne J, Lapointe N, Barrette S et al. Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Bone Marrow Transplant 2002; 30: 979-981.
9. Le Deist-F, Blanche S, Keable H, Gaud C, Pham H, Descamp-Latscha B et al. Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood 1989; 74 512-516.
10. Linial ML, Fan H, Hahn B, Lwer R, Neil J, Quackenbusch S et al. Retroviridae. In: Fauquet CM (ed). Virus Taxonomy. Elsevier Inc.: Oxford, 2005, pp 421-440.
11. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007 - an update. J Gene Med 2007; 9: 833-842.
12. Linial M. Foamy viruses. In. DM Kniepe and PM Howley (eds). Fields Virology, 5th edn. Lippincot Williams & Wilkins: Philadelphia, 2007, pp 2245-2262.
13. Rethwilm A. Foamy viruses. In: Mahy BWJ and Meulen V ter (eds). Topley & Wilson's Microbiology and Microbial Infections - Virology, 10th edn. Hodder Arnold: London, 2005, pp 1304-1321.
14. Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, Bock M et al. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997; 71: 7305-7311.
15. Roy J, Rudolph W, Juretzek T, Gärtner K, Bock M, Herchenröder O et al. Feline foamy virus genome and replication strategy. J Virol 2003; 77: 11324-11331.
16. Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J Virol 1999; 73: 1565-1572.
17. Trobridge G, Russell DW. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004; 78: 2327-2335.
18. Lindemann D, Goepfert PA. The foamy virus envelope glycoproteins. Curr Top Microbiol Immunol 2003; 277: 111-129.
19. Rethwilm A. Foamy virus vectors: An awaited alternative to gammaretro- and lentiviral vectors. Curr Gene Ther 2007; 7: 261-271.
20. Löchelt M, Zentgraf H, Flügel RM. Construction of an infectious DNA clone of the full-length human spumaretro-virus genome and mutagenesis of the bel 1 gene. Virology 1991; 184: 43-54.
21. Rethwilm A, Baunach G, Netzer KO, Maurer B, Borisch B, ter Meulen V. Infectious DNA of the human spumaretrovirus. Nucleic Acids Res 1990; 18: 733-738.
22. Achong BG, Mansell PW, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971; 46: 299-307.
23. Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J et al. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology 1994; 201: 187-199.
24. Heinkelein M, Dressler M, Jármy G, Rammling M, Imrich H, Thurow J et al. Improved primate foamy virus vectors and packaging constructs. J Virol 2002; 76: 3774-3783.
25. Trobridge G, Josephson N, Vassilopoulos G, Mac J, Russell DW. Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002; 6: 321-328.
26. Hill CL, Bieniasz PD, McClure MO. Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 1999; 80: 2003-2009.
27. Trobridge G, Vassilopoulos G, Josephson N, Russell DW. Gene transfer with foamy virus vectors. Methods Enzymol 2002; 346: 628-648.
28. Kiem HP, Allen J, Trobridge G, Olson E, Keyser K, Peterson L et al Foamy virus-mediated gene transfer to canine repopulating cells. Blood 2007; 109: 65-70.
29. + cord blood cells. Hum Gene Ther 2003; 14: 509-519.
30. Nowrouzi A, Dittrich M, Klanke C, Heinkelein M, Rammling M, Dandekar T et al. Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol 2006; 87: 1339-1347.
31. Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R et al Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 2006; 103: 1498-1503.
32. Josephson NC, Trobridge G, Russell DW. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum Gene Ther 2004, 15: 87-92.
33. Vassilopoulos G, Trobridge G, Josephson NC, Russell DW. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 2001; 98: 604-609.
34. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422: 901-904.
35. Hendrie PC, Huo Y, Stolitenko RB, Russell DW. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol Ther 2008; 16: 534-540.
36. Switzer WM, Salemi M, Shanmugam V, Gao F, Cong ME, Kuiken C et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005; 434: 376-380.
37. Thümer L, Rethwilm A, Holmes EC, Bodem J. The complete nucleotide sequence of a New World simian foamy virus. Virology 2007; 369 191-197.
38. Heneine W, Schweizer M, Sandstrom P, Folks T. Human infection with foamy viruses. Curr Top Microbial Immunol 2003; 277: 181-196.
39. Boneva RS, Switzer WM, Spira TJ, Bhullar VB, Shanmugam V, Cong ME et al. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res Hum Retroviruses 2007; 23: 1330-1337.
40. Trowald-Wigh G, Håkansson L, Johannisson A, Norrgren L, Hård af Segerstad C. Leucocyte adhesion protein deficiency in Irish setter dogs. Vet Immunol Immunopathol 1992; 32: 261-280.
41. Bauer Jr TR, Hai M, Tuschong LM, Burkholder TH, Gu YC, Sokolic RA et al. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 2000, 108: 3313-3320.
42. Taylor JA, Voitech L, Balmer I, Kohn DB, Laer DV, Russell DW et al Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Mol Ther 2008; 16: 46-51.
43. Pietschmann T, Heinkelein K Heldmann M, Zentgraf H, Rethwilm A, Lindemann D. Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999; 73: 2613-2621.